TRAVIS HARDIN: Open Payments
NPI 1831503259 · BLUE RIDGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 27 payments from 10 companies in 2025. Trend: 2023 $317 · 2024 $311 · 2025 $689
Food & beverage: $625Education: $65
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 8 | $302 |
| Novo Nordisk Inc | 5 | $118 |
| ABBVIE INC. | 4 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $23 |
| PFIZER INC. | 1 | $20 |
| Exact Sciences Corporation | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: Korlym, REXULTI, VRAYLAR, XIFAXAN, Quviviq, NURTEC ODT, UBRELVY, Cologuard Collection Kit.
Industry payments across GA — which companies pay providers there.
